Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibha Jawa

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Journal of Pharmaceutical Sciences|December 14, 2020
The Impact of Product and Process Related Critical Quality Attributes on Immunogenicity and Adverse Immunological Effects of BiotherapeuticsYi Wen, Vibha Jawa
The AAPS Journal|March 13, 2012
Immunogenicity to therapeutic proteins: impact on PK/PD and efficacyNarendra Chirmule, Vibha Jawa, Bernd Meibohm
The AAPS Journal|October 4, 2017
How Close Are We to Profiling Immunogenicity Risk Using In Silico Algorithms and In Vitro Methods?: an Industry PerspectiveJochem Gokemeijer, Vibha Jawa, Shibani Mitra-Kaushik
Bioanalysis|October 22, 2013
Universal immunogenicity validation and assessment during early biotherapeutic development to support a green laboratoryAmi C Bautista, Lei Zhou, Vibha Jawa
Journal of Pharmaceutical Sciences|July 30, 2020
Failure Mode and Effects Analysis (FMEA) for Immunogenicity of Therapeutic ProteinsNarendra Chirmule, Ravindra Khare, Atul Khandekar, et al.
The AAPS Journal|January 18, 2021
Competition-Based Cell Assay Employing Soluble T Cell Receptors to Assess MHC Class II Antigen Processing and PresentationCarley Tasker, Jenny Patel, Vibha Jawa, et al.
The AAPS Journal|September 4, 2012
Universal immunoassay applied during early development of large molecules to understand impact of immunogenicity on biotherapeutic exposureAmi C Bautista, Hossein Salimi-Moosavi, Vibha Jawa
Bioanalysis|December 18, 2013
Immunogenicity and PK/PD evaluation in biotherapeutic drug development: scientific considerations for bioanalytical methods and data analysisYow-Ming C Wang, Vibha Jawa, Mark Ma
Pharmaceutics|July 30, 2025
A Semi-Mechanistic Mathematical Model of Immune Tolerance Induction to Support Preclinical Studies of Human Monoclonal Antibodies in RatsParidhi Gupta, Josiah T Ryman, Vibha Jawa, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 22, 2025
Mechanism-Based Modeling Approaches to Quantify the Effect of Immunogenicity on the Pharmacokinetics of Therapeutic Proteins in Drug DevelopmentParidhi Gupta, Josiah T Ryman, Vibha Jawa, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Journal of Pharmaceutical Sciences|December 14, 2020
The Impact of Product and Process Related Critical Quality Attributes on Immunogenicity and Adverse Immunological Effects of BiotherapeuticsYi Wen, Vibha Jawa
The AAPS Journal|March 13, 2012
Immunogenicity to therapeutic proteins: impact on PK/PD and efficacyNarendra Chirmule, Vibha Jawa, Bernd Meibohm
The AAPS Journal|October 4, 2017
How Close Are We to Profiling Immunogenicity Risk Using In Silico Algorithms and In Vitro Methods?: an Industry PerspectiveJochem Gokemeijer, Vibha Jawa, Shibani Mitra-Kaushik
Bioanalysis|October 22, 2013
Universal immunogenicity validation and assessment during early biotherapeutic development to support a green laboratoryAmi C Bautista, Lei Zhou, Vibha Jawa
Journal of Pharmaceutical Sciences|July 30, 2020
Failure Mode and Effects Analysis (FMEA) for Immunogenicity of Therapeutic ProteinsNarendra Chirmule, Ravindra Khare, Atul Khandekar, et al.
The AAPS Journal|January 18, 2021
Competition-Based Cell Assay Employing Soluble T Cell Receptors to Assess MHC Class II Antigen Processing and PresentationCarley Tasker, Jenny Patel, Vibha Jawa, et al.
The AAPS Journal|September 4, 2012
Universal immunoassay applied during early development of large molecules to understand impact of immunogenicity on biotherapeutic exposureAmi C Bautista, Hossein Salimi-Moosavi, Vibha Jawa
Bioanalysis|December 18, 2013
Immunogenicity and PK/PD evaluation in biotherapeutic drug development: scientific considerations for bioanalytical methods and data analysisYow-Ming C Wang, Vibha Jawa, Mark Ma
Pharmaceutics|July 30, 2025
A Semi-Mechanistic Mathematical Model of Immune Tolerance Induction to Support Preclinical Studies of Human Monoclonal Antibodies in RatsParidhi Gupta, Josiah T Ryman, Vibha Jawa, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 22, 2025
Mechanism-Based Modeling Approaches to Quantify the Effect of Immunogenicity on the Pharmacokinetics of Therapeutic Proteins in Drug DevelopmentParidhi Gupta, Josiah T Ryman, Vibha Jawa, et al.
Pageof 8